Cohiba Minerals Limited (CHKMF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 1.6 Million | 1.54 Million | 1.16 Million | 1.07 Million | 648.09 Thousand | 689.95 Thousand |
| Selling, General and Administrative Expenses | 1.6 Million | 1.54 Million | 1.16 Million | 1.07 Million | 648.09 Thousand | 689.95 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | 10 Thousand | -273.15 Thousand | - |
| Cost and Expenses | 1.6 Million | 1.54 Million | 1.16 Million | 1.07 Million | 648.09 Thousand | 689.95 Thousand |
| Operating Income | -1.6 Million | -1.54 Million | -1.16 Million | -1.07 Million | -648.09 Thousand | -689.95 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -1.67 Million | -2109.16 | -1147.57 | -79.54 | -78.54 | -600.86 Thousand |
| Earnings before Tax | -3.26 Million | -3.64 Million | -1.95 Million | -1.04 Million | -887.42 Thousand | -769.61 Thousand |
| Net Income | -3.26 Million | -3.64 Million | -1.95 Million | -1.04 Million | -887.42 Thousand | -769.61 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 2.83 Billion | 1.73 Billion | 1.42 Billion | 1.19 Billion | 687.23 Million | 616.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.84 Billion | 1.73 Billion | 1.42 Billion | 1.19 Billion | 687.23 Million | 616.39 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.6 Million | -1543.87 | -1.69 Million | -1.42 Million | -648.09 Thousand | -1.11 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 443.98 Thousand | 637.45 Thousand | 549.71 Thousand | 1.02 Million | 489.55 Thousand | 535.05 Thousand |
| Selling, General and Administrative Expenses | 443.98 Thousand | 637.45 Thousand | 549.71 Thousand | - | 489.55 Thousand | 535.05 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 443.98 Thousand | 637.45 Thousand | 549.71 Thousand | 1.02 Million | 489.55 Thousand | 535.05 Thousand |
| Operating Income | -443.98 Thousand | -637.46 Thousand | -549.71 Thousand | -1.02 Million | -489.55 Thousand | -535.04 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 1.00 | - | -43.81 Thousand | -2108.16 | -122.08 Thousand | -54.87 Thousand |
| Earnings before Tax | -1.11 Million | -1.07 Million | -1.95 Million | -2.42 Million | -486.72 Thousand | -1.32 Million |
| Net Income | -1.11 Million | -1.07 Million | -1.95 Million | -2.42 Million | -486.72 Thousand | -1.32 Million |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 3.87 Billion | 2.21 Billion | 2.11 Billion | 1.73 Billion | 1.77 Billion | 1.44 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.87 Billion | 2.21 Billion | 2.11 Billion | 1.73 Billion | 1.77 Billion | 1.44 Billion |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.11 Million | -637.46 Thousand | -549.71 Thousand | - | -489.55 Thousand | -535.04 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
VIVOBIOT
9644
4114
EWRC
AGYS
PNC